4 Results for "

GSK 3685032

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "GSK 3685032" in MCE Product Catalog:

  • Categories Recommended:
    More
15
15 Cited Publications
Cat. No.: HY-139664
CAS No.: 2170137-61-6
Purity:  99.95%
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition .
loading...
    loading...
Cat. No.: HY-139664A
CAS No.: 2170140-50-6
Purity:  98.97%
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032 (HY-139664) and is a potent, non-covalent, reversible DNMT1-selective inhibitor with an IC50 of 0.036 μM against DNMT1. (R)-GSK-3685032 preferentially binds DNMT1 in a hemimethylated DNA context, inhibits DNA methylation maintenance by occupying the DNMT1 active site loop that inserts into DNA and by interacting with the target recognition domain, thereby inducing DNA hypomethylation and transcriptional activation. (R)-GSK-3685032 is useful for research on DNMT1, acute myeloid leukemia, and B cell humoral immunity .
loading...
    loading...
Cat. No.: HY-139664B
CAS No.: 2170142-58-0
Purity:  98.82%
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

(S)-GSK-3685032 is the isomer of GSK-3685032 (HY-139664), and can be used as an experimental control. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition .
loading...
    loading...
Cat. No.: HY-139664R
CAS No.: 2170137-61-6
Research Areas:  

Cancer

GSK-3685032 (Standard) is the analytical standard of GSK-3685032 (HY-139664). This product is intended for research and analytical applications. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition .
loading...
    loading...